Stereotactic body radiotherapy for patients with unresectable primary hepatocellular carcinoma: dose-volumetric parameters predicting the hepatic complication.

[1]  H. Jang,et al.  Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: preliminary analysis , 2008, BMC Cancer.

[2]  Maria Hawkins,et al.  Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  E. Kunieda,et al.  Hypofractionated stereotactic radiotherapy with and without transarterial chemoembolization for small hepatocellular carcinoma not eligible for other ablation therapies: Preliminary results for efficacy and toxicity , 2008, Hepatology research : the official journal of the Japan Society of Hepatology.

[4]  Chang-Min Kim,et al.  Hepatitis B virus reactivation after three-dimensional conformal radiotherapy in patients with hepatitis B virus-related hepatocellular carcinoma. , 2007, International journal of radiation oncology, biology, physics.

[5]  Xiao-dong Zhu,et al.  Prediction of radiation induced liver disease using artificial neural networks. , 2006, Japanese journal of clinical oncology.

[6]  Hai-jie Lu,et al.  Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: the risk factors and hepatic radiation tolerance. , 2006, International journal of radiation oncology, biology, physics.

[7]  H. Jang,et al.  Fractionated stereotactic radiotherapy in patients with primary hepatocellular carcinoma. , 2006, Japanese journal of clinical oncology.

[8]  C. Suh,et al.  Local radiotherapy as a complement to incomplete transcatheter arterial chemoembolization in locally advanced hepatocellular carcinoma , 2005, Liver international : official journal of the International Association for the Study of the Liver.

[9]  J. Furuse,et al.  Adverse hepatic events caused by radiotherapy for advanced hepatocellular carcinoma , 2005, Journal of gastroenterology and hepatology.

[10]  M. Choi,et al.  Local radiotherapy for patients with unresectable hepatocellular carcinoma. , 2005, International journal of radiation oncology, biology, physics.

[11]  Yi-Cheng Chen,et al.  Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm. , 2004, Gastroenterology.

[12]  Daniel Normolle,et al.  Analysis of radiation-induced liver disease using the Lyman NTCP model. , 2002, International journal of radiation oncology, biology, physics.

[13]  Pietro Andreone,et al.  Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. , 2002, Radiology.

[14]  S. H. Cheng,et al.  Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication. , 2001, International journal of radiation oncology, biology, physics.

[15]  Jacques Ferlay,et al.  Estimating the world cancer burden: Globocan 2000 , 2001, International journal of cancer.

[16]  E F Halpern,et al.  Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. , 2001, Radiology.

[17]  C. Horng,et al.  Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma. , 2000, International journal of radiation oncology, biology, physics.

[18]  K. Han,et al.  Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma. , 1999, International journal of radiation oncology, biology, physics.

[19]  M. Kessler,et al.  A phase I trial of hepatic arterial bromodeoxyuridine and conformal radiation therapy for patients with primary hepatobiliary cancers or colorectal liver metastases. , 1997, International journal of radiation oncology, biology, physics.

[20]  M. Cottone,et al.  Treatment of small hepatocellular carcinoma associated with cirrhosis by percutaneous ethanol injection. A trial with a comparison group. , 1997, Scandinavian journal of gastroenterology.

[21]  M. Anscher,et al.  Hepatic toxicity resulting from cancer treatment. , 1995, International journal of radiation oncology, biology, physics.

[22]  H. Hasegawa,et al.  Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patients , 1985, Cancer.

[23]  D. Brinkley,et al.  Quadruple chemotherapy versus radiotherapy in treatment of primary hepatocellular carcinoma , 1977, Cancer.

[24]  K. Lewin,et al.  Human radiation hepatitis. A morphologic study with emphasis on the late changes. , 1973, Archives of pathology.

[25]  K. Hizawa,et al.  HEPATIC INJURY FOLLOWING IRRADIATION--A MORPHOLOGIC STUDY--. , 1963, The Tokushima journal of experimental medicine.

[26]  J. Seong,et al.  Radiotherapeutic parameters predictive of liver complications induced by liver tumor radiotherapy. , 2009, International Journal of Radiation Oncology, Biology, Physics.

[27]  Tae Hyun Kim,et al.  Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy. , 2007, International journal of radiation oncology, biology, physics.

[28]  F. Lohr,et al.  Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  C. Bartolozzi,et al.  Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis: a European experience , 1997, European Radiology.